文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Vaccines: correlates of vaccine-induced immunity.

作者信息

Plotkin Stanley A

机构信息

Sanofi Pasteur, Doylestown, Pennsylvania, USA.

出版信息

Clin Infect Dis. 2008 Aug 1;47(3):401-9. doi: 10.1086/589862.


DOI:10.1086/589862
PMID:18558875
Abstract

The immune system is redundant, and B and T cells collaborate. However, almost all current vaccines work through induction of antibodies in serum or on mucosa that block infection or interfere with microbial invasion of the bloodstream. To protect, antibodies must be functional in the sense of neutralization or opsonophagocytosis. Correlates of protection after vaccination are sometimes absolute quantities but often are relative, such that most infections are prevented at a particular level of response but some will occur above that level because of a large challenge dose or deficient host factors. There may be >1 correlate of protection for a disease, which we term "cocorrelates." Either effector or central memory may correlate with protection. Cell-mediated immunity also may operate as a correlate or cocorrelate of protection against disease, rather than against infection. In situations where the true correlate of protection is unknown or difficult to measure, surrogate tests (usually antibody measurements) must suffice as predictors of protection by vaccines. Examples of each circumstance are given.

摘要

相似文献

[1]
Vaccines: correlates of vaccine-induced immunity.

Clin Infect Dis. 2008-8-1

[2]
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.

Expert Rev Vaccines. 2004-2

[3]
A framework for assessing immunological correlates of protection in vaccine trials.

J Infect Dis. 2007-11-1

[4]
On immunity against infections and vaccines: credo 2004.

Scand J Immunol. 2004

[5]
Booster vaccinations: can immunologic memory outpace disease pathogenesis?

Pediatrics. 2009-12

[6]
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Nat Med. 2004-8

[7]
Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.

Vaccine. 2008-12-9

[8]
Vaccines against intracellular infections requiring cellular immunity.

Nature. 2000-8-17

[9]
Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.

Med Hypotheses. 2008-12

[10]
[New vaccines and the immune response (I). Immunologic memory. Humoral response versus cellular response].

Med Clin (Barc). 1996-6-22

引用本文的文献

[1]
Immune Reconstitution and Need for Booster Vaccinations Among Non-Transplant Childhood Cancer Survivors: A Single-Center Experience.

Cancer Rep (Hoboken). 2025-9

[2]
Safety and Toxicology Profile of TT-6-AmHap Heroin Conjugate Vaccine.

Vaccines (Basel). 2025-7-26

[3]
Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity.

Microorganisms. 2025-7-31

[4]
Immune Biomarkers, Profiles, and Responses: A Vaccine Ontology Perspective.

bioRxiv. 2025-7-22

[5]
Protective IgM-mediated immunity against in Atlantic cod with evolutionary losses of and .

Front Immunol. 2025-7-2

[6]
Reinfection with a Bacterial Pathogen Augments Heterogeneity in Host Disease Responses.

Res Sq. 2025-7-3

[7]
Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic colonization.

Infect Immun. 2025-6-10

[8]
Evaluating Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Influenza: A Sensitivity Analysis Based on Information Theory and Causal Inference.

J Glob Infect Dis. 2025-2-24

[9]
Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.

Sci Rep. 2025-3-6

[10]
Proof-of-principle of a technology transfer of a dried blood virus neutralisation assay to a Gavi-eligible country.

BMJ Glob Health. 2025-3-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索